Usmangani Chhalotiya | Analytical Method Development | Academic Visionary Discovery Award

Dr. Usmangani Chhalotiya | Analytical Method Development | Academic Visionary Discovery Award

Associate Professor | Indukaka Ipcowala College of Pharmacy | India

Dr. Usmangani K. Chhalotiya is an accomplished pharmaceutical scientist and academician specializing in Quality Assurance, Analytical Method Development, and Bioanalytical Validation, with over a decade of impactful contributions to pharmaceutical research and education. He earned his Ph.D. in Pharmaceutical Sciences from Sardar Patel University, V.V. Nagar, in 2013, following his M. Pharm. in Quality Assurance (2008) and B. Pharm. (2006) from the same university, establishing a strong foundation in pharmaceutical sciences. Currently serving as Associate Professor at Indukaka Ipcowala College of Pharmacy, CVM University, Anand, Gujarat since 2009, he has guided 22 M. Pharm. dissertations, mentored Ph.D. scholars, coordinated institutional Ph.D. programs, and actively contributed to curriculum development as a member of the Board of Studies. His research interests span impurity profiling, impurity characterization using LC-MS/MS, NMR, IR, and the development of robust analytical methods aligned with ICH and cGMP guidelines, ensuring scientific rigor and industrial relevance. He is proficient in chromatographic techniques (HPLC, HPTLC, GC), bioanalytical method validation, and advanced sample preparation approaches, with a strong command of data interpretation and literature analysis. Dr. Chhalotiya has published more than 60 papers in reputed peer-reviewed journals indexed in Scopus and IEEE, co-authored a book, delivered expert talks at state and national conferences, and secured research grants from GUJCOST, GSBTM, and GSPC for organizing seminars, workshops, and conferences. His achievements include receiving the prestigious P. D. Sethi Award (2013–2021) for his outstanding contributions to analytical chemistry research. He has also served as ISO system representative, PCI portal coordinator, and industry–academic collaborator, reflecting his leadership in academia and community service. With dedication to advancing pharmaceutical sciences, mentoring young researchers, and expanding global collaborations, Dr. Chhalotiya continues to demonstrate scholarly excellence and leadership potential. 406 Citations by 370 documents | 61 Documents | 12 h-index.

Profile: Google Scholar | Scopus ORCID

Featured Publications

  1. Choudhary, D. R., Patel, V. A., Chhalotiya, U. K., Patel, H. V., & Kundawala, A. J. (2012). Development and characterization of pharmacokinetic parameters of fast-dissolving films containing levocetirizine. Scientia Pharmaceutica, 80(3), 779. Cited by: 71

  2. Chhalotiya, U. K., Bhatt, K. K., Shah, D. A., & Baldania, S. L. (2010). Development and validation of a stability-indicating RP-HPLC method for duloxetine hydrochloride in its bulk and tablet dosage form. Scientia Pharmaceutica, 78(4), 857. Cited by: 50

  3. Patel, K. P., Chhalotiya, U. K., Kachhiya, H. M., & Patel, J. K. (2020). A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form. Future Journal of Pharmaceutical Sciences, 6(1), 80. Cited by: 31

  4. Shah, D. A., Gondalia, I. I., Patel, V. B., Mahajan, A., & Chhalotiya, U. K. (2020). Stability indicating liquid chromatographic method for the estimation of remogliflozin etabonate. Journal of Chemical Metrology, 14(2), 125–132. Cited by: 31

  5. Choudhary, D. R., Patel, V. A., Chhalotiya, U. K., Patel, H. V., & Kundawala, A. J. (2011). Formulation and evaluation of fast dissolving film of levocetirizine dihydrochloride using different grades of methocel. Journal of Pharmacy Research, 4(9), 2919–2924.Cited by: 29

Zhendong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Mr. Zhendong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Phd student at University of Cologne, Germany

Mr. Zhendong Chen is a dedicated and accomplished researcher specializing in clinical pharmacology, pharmacokinetics, and pharmacometrics, with extensive experience in both academic and industry settings. Currently pursuing his PhD at the University of Cologne under the supervision of Professor Uwe Fuhr, Mr. Chen has contributed significantly to the development of population pharmacokinetic models, innovative joint modeling approaches, and advanced data analysis techniques. His research spans drug metabolism, renal function assessment, and therapeutic drug monitoring, demonstrating his versatility and technical expertise. With several peer-reviewed publications in respected journals, Mr. Chen has established a strong scientific presence, contributing valuable insights to drug development and personalized medicine. His collaborative work with institutions like Johnson & Johnson further highlights his ability to translate complex data into clinically relevant solutions. With his strong analytical skills, international experience, and commitment to advancing pharmacological science, Mr. Chen is a promising and highly capable researcher in his field.

Professional Profile 

  • Google Scholar
  • Scopus Profile
  • ORCID Profile

Education

Mr. Zhendong Chen has built a strong academic foundation through comprehensive education and specialized training in pharmacy, drug metabolism, and clinical pharmacology. He earned his Bachelor’s degree in Pharmacy from Sichuan University’s prestigious West China School of Pharmacy, where he developed a solid understanding of pharmaceutical sciences. Following this, he pursued a Master’s degree at the Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, under the supervision of Professor Dafang Zhong, focusing on drug metabolism and pharmacokinetics. During his time at SIMM, he gained valuable experience in both non-clinical and clinical pharmacokinetic studies, refining his expertise in analytical techniques and pharmacokinetic modeling. Currently, Mr. Chen is pursuing his PhD at the University of Cologne, Germany, under the guidance of Professor Uwe Fuhr. His doctoral research centers on clinical pharmacology and pharmacometrics, emphasizing population pharmacokinetics and innovative modeling strategies, further solidifying his academic and research credentials.

Professional Experience

Mr. Zhendong Chen has accumulated extensive professional experience across academic institutions, research institutes, and the pharmaceutical industry, with a focus on clinical pharmacology, pharmacokinetics, and pharmacometrics. Currently a PhD researcher at the University of Cologne, he is actively involved in developing innovative pharmacometric models to assess renal function, drug disposition, and pharmacogenetic influences. His work spans population pharmacokinetics, joint modeling strategies, and therapeutic drug monitoring in complex clinical settings, including cerebrospinal fluid drug penetration in critically ill patients. Prior to his PhD, Mr. Chen contributed to multiple non-clinical and clinical pharmacokinetic studies at the Shanghai Institute of Materia Medica, where he honed his expertise in bioanalysis and drug metabolism. His ongoing collaboration with Johnson & Johnson further enhances his experience in applying pharmacometric techniques to drug development, including exposure-response modeling and longitudinal data analysis. His broad professional background reflects strong analytical skills, multidisciplinary collaboration, and a commitment to advancing drug research and development.

Research Interest

Mr. Zhendong Chen’s research interests lie at the intersection of clinical pharmacology, pharmacometrics, and drug metabolism, with a particular focus on improving drug development and personalized medicine through advanced modeling techniques. He is passionate about developing population pharmacokinetic (popPK) and pharmacodynamic (PD) models to better understand the factors influencing drug absorption, distribution, metabolism, and excretion in diverse patient populations. His work also explores the impact of genetic polymorphisms, renal and hepatic function, and disease states on drug pharmacokinetics and pharmacodynamics, contributing to precision dosing strategies. Additionally, Mr. Chen is interested in joint modeling approaches, combining biomarker data with pharmacokinetic and clinical outcome data to enhance drug efficacy and safety predictions. His current work extends to therapeutic drug monitoring, drug penetration into cerebrospinal fluid, and the evaluation of novel methods for assessing renal function using pharmacometric tools, showcasing his dedication to advancing clinically relevant, data-driven drug research.

Award and Honor

Mr. Zhendong Chen has demonstrated exceptional academic and research excellence, earning several awards and honors throughout his educational and professional journey. During his undergraduate and graduate studies, he consistently achieved top rankings in his class, reflecting his strong academic performance and dedication to pharmaceutical sciences. His research contributions in clinical pharmacology, pharmacokinetics, and pharmacometrics have also been recognized through conference presentations and peer-reviewed publications in high-impact journals. In recognition of his outstanding research potential, Mr. Chen was selected for a prestigious research collaboration with Johnson & Johnson, where he applies advanced modeling techniques to drug development projects. Additionally, his collaborative work on innovative pharmacometric modeling strategies has been highlighted in international research forums, further cementing his reputation as a promising young researcher. Through his strong scientific output, collaborative spirit, and consistent commitment to excellence, Mr. Chen continues to build a distinguished profile in the global pharmaceutical research community.

Research skill

Mr. Zhendong Chen possesses a diverse and advanced set of research skills that span across clinical pharmacology, pharmacokinetics, pharmacometrics, and drug metabolism. He is highly proficient in population pharmacokinetic (popPK) and pharmacodynamic (PD) modeling, using software such as NONMEM for model development, covariate analysis, and model diagnostics. His expertise also extends to data processing and visualization using R, including programming custom scripts for data handling, analysis, and graphical presentation. Mr. Chen has hands-on experience with non-compartmental analysis (NCA), bioanalytical method development, and therapeutic drug monitoring, particularly in complex clinical scenarios such as cerebrospinal fluid drug penetration. His skills further include applying semi-mechanistic modeling approaches to integrate pharmacogenetics, disease progression, and organ function assessments into predictive models. With strong analytical thinking, problem-solving abilities, and interdisciplinary collaboration experience, Mr. Chen is adept at translating complex pharmacokinetic data into meaningful insights that guide dose optimization and personalized medicine strategies.

Conclusion

Zhendong Chen is a very strong candidate for a Best Researcher Award, particularly in the field of pharmacokinetics, pharmacometrics, and clinical pharmacology. His consistent publication output, diverse international research experience, technical expertise, and innovative projects make him highly competitive.

Ramu Samineni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr Ramu Samineni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Joy University, Raja Nagar, Vadakangulam, near kanyakumari, Tamil Nadu, India

Ramu Samineni is a dedicated academic and researcher with over 12 years of experience in pharmaceutical sciences. Currently serving as an Associate Professor at Sandip University, Maharashtra, he has previously held teaching positions at several prestigious institutions, including Vignan’s University and MB University. Ramu is well-regarded for his contributions to student mentorship, academic research, and his active involvement in developing innovative teaching methods. His work extends beyond the classroom, with multiple publications, patents, and research collaborations that contribute to his growing reputation in the pharmaceutical field.

Professional Profile

Education

Ramu holds a Ph.D. in Pharmaceutical Sciences from Vignan’s Foundation for Science, Technology, and Research, Guntur, where he focused on designing and characterizing novel cocrystal tablets for improved drug delivery. He completed his Master’s in Pharmacy (Pharmaceutics) at SRM University, Chennai, and earned a Bachelor of Pharmacy from Annamalai University. His academic foundation in pharmaceutical technology and drug delivery systems has driven his innovative research in cocrystals, nanoparticles, and solid lipid formulations.

Professional Experience

Ramu Samineni has a wealth of professional experience, beginning his academic career in 2011. He has served as an Assistant Professor at institutions like Vignan’s University and MB University before his current role as an Associate Professor at Sandip University. Throughout his career, Ramu has not only been involved in teaching but also in developing pharmaceutical research agendas, conducting laboratory sessions, and guiding both undergraduate and postgraduate students. His involvement in fundamental research projects and grant acquisition underscores his commitment to advancing the field of pharmaceutical sciences.

Research Interest

Ramu’s research interests lie in the areas of cocrystals, novel drug delivery systems, floating microspheres, and solid lipid nanoparticles. His work focuses on enhancing the solubility and bioavailability of drugs, particularly those classified as Biopharmaceutics Classification System (BCS) II and III, through innovative formulation techniques. He has also explored mouth-disintegrating tablets and the potential of 3D printing in drug delivery. His diverse research portfolio is reflected in his numerous publications, patents, and his active participation in academic conferences.

Awards and Honors

Ramu Samineni has been recognized for his contributions to pharmaceutical research and education with several prestigious awards. He has received research grants from the Council of Scientific and Industrial Research (CSIR) and Sandip University, totaling 3 Lakhs. His work in pharmaceutical innovation has also led to the granting of three patents, with nine more patents published. Ramu has been honored with three awards for his academic and research excellence and has been invited to present at numerous national and international conferences, further solidifying his status as a leader in pharmaceutical sciences.

Conclusion

Ramu Samineni has a strong academic and research profile with significant contributions to pharmaceutical sciences, making him a competitive candidate for the Best Researcher Award. His strengths lie in his diverse research output, patent activity, and dedication to teaching and mentoring. However, improving his citation metrics and expanding his research collaborations could further enhance his candidacy for this prestigious recognition.

Publication top noted

  • “Introduction to Nutrition and Autoimmune Diseases”
    📚 Bukke, S.P.N., Kumarachari, R.K., Swetha, M., Yadesa, T., Samineni, R.
    📅 2024, pp. 1–29
    🔗 Journal: Nutrition Controversies and Advances in Autoimmune Disease
    🔄 0 Citations
  • “IN SILICO Molecular Docking Studies of Coumarin-Chalcone Hybrids Against SARS-CoV-2 Main Protease (6LU7)”
    📚 Konidala, S.K., Kotra, V., Samineni, R., Jamullamudi, R.N., Kola, P.K.
    📅 2024, 61(5), pp. 24–31
    🔗 Journal: Indian Drugs
    🔄 0 Citations
  • “Simultaneous Quantification of Gemcitabine and Oxaliplatin by RP-HPLC in Bulk and Synthetic Mixture”
    📚 Kolakaluri, C.S., Kamala, G., Konidala, S.K., Samineni, R.
    📅 2024, 13(1), 34
    🔗 Journal: Letters in Applied NanoBioScience
    🔄 0 Citations
  • “Formulation and Evaluation of Mixed Micelles Containing Quercetin for Inhibiting Intestinal Metabolism of Atorvastatin”
    📚 Palei, N.N., Rajangam, J., Samineni, R., Dhar, A.K., Balaji, A.
    📅 2024, 49(1), pp. 51–64
    🔗 Journal: Fabad Journal of Pharmaceutical Sciences
    🔄 0 Citations
  • “Plants as Regular Phytochemical Sources of Dentistry – Formulation and Evaluation of Polyherbal Toothpaste”
    📚 Matangi, S.P., Samineni, R., Kumar, K., Raju, M.S.
    📅 2024, 24(2), pp. 397–407
    🔗 Journal: Journal of Natural Remedies
    🔄 0 Citations
  • “Design and Characterization of Oral Mucoadhesive Buccal Films of Empagliflozin”
    📚 Samineni, R., Firoz, S., Bandaru, N., Gouru, S.A., Sivakumar, M.
    📅 2023, 16(12), pp. 5576–5580
    🔗 Journal: Research Journal of Pharmacy and Technology
    🔄 0 Citations
  • “IN SILICO, Antimicrobial and Cytotoxic Studies of Carboxamide Derivatives and Their Green Synthesis”
    📚 Thumula, S., Srinivasadesikan, V., Kottalanka, R.K., Samineni, R.
    📅 2023, 60(10), pp. 19–31
    🔗 Journal: Indian Drugs
    🔄 0 Citations
  • “Hepatoprotective, Antioxidant and Anti-Inflammatory Potential of Lentinula edodes Extract Against Diclofenac-Induced Hepatic Damage in Wistar Rats”
    📚 Reddy, G.S.K., Kumar, B.V.V.R., Prabha, M.S., Samineni, R., Anitha, G.M.R.
    📅 2023, 12(6), 236248
    🔗 Journal: Journal of Drug and Alcohol Research
    🔄 0 Citations
  • “Synthesis and In-vivo Bioactivity Studies of Some New Hydrazide Schiff Bases and Mannich Bases of Indole Derivatives”
    📚 Subramanyam, S., Samineni, R., Kadiri, S.K., Chikkula, K.V., Gouru, S.A.
    📅 2023, 33(3), pp. 299–309
    🔗 Journal: Indian Journal of Heterocyclic Chemistry
    🔄 0 Citations
  • “Development and Validation of UPLC-MS/MS Method for Simultaneous Determination of Multi-Class Antibiotics, Antivirals, and Antifungals in Water”
    📚 Siva Shanmugam, S., Narayanan, S., Shandil, R.K., Pulusu, V.S., Sri, K.H.
    📅 2023, 35(10), pp. 2509–2516
    🔗 Journal: Asian Journal of Chemistry
    🔄 0 Citations